#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12070	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2285	645.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1487	1487	C	836	C	836	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12070	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2285	645.0	0	HET	.	.	.	C611T,G	.	611	611	C	914	914	C	742	C,T,G	362,378,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19948	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3959	628.0	0	.	n	.	0	T695C	SNP	695	695	T	1205	1205	C	796	C,T	795,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19948	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3959	628.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1847	1847	A	832	A	832	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19948	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3959	628.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2481	2481	C	689	C,A	688,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19948	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3959	628.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3107	3107	T	701	T,C	700,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19948	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3959	628.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2555	2555	A	611	A,C	610,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1928	folP	852	852	100.0	folP.l6.c17.ctg.1	1784	134.6	1	SNP	p	R228S	1	.	.	682	684	AGC	1138	1140	AGC	207;209;208	A,C;G;C,T	206,1;209;207,1	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4834	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3738	161.1	1	SNP	p	S91F	0	.	.	271	273	TCC	809	811	TCC	191;190;190	T;C;C	191;190;190	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4834	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3738	161.1	1	SNP	p	D95G	0	.	.	283	285	GAC	821	823	GAC	190;191;189	G;A;C	190;191;189	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4834	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3738	161.1	1	SNP	p	D95N	0	.	.	283	285	GAC	821	823	GAC	190;191;189	G;A;C	190;191;189	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1760	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1688	130.2	1	SNP	p	G45D	1	.	.	133	135	GAC	637	639	GAC	204;205;208	G;A;C	204;205;208	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1086	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c4.ctg.1	1205	112.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4418	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3474	158.6	1	SNP	p	D86N	0	.	.	256	258	GAC	794	796	GAC	204;208;209	G;A,C;C	204;207,1;209	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4418	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3474	158.6	1	SNP	p	S87I	0	.	.	259	261	AGT	797	799	AGT	206;207;207	A,T;G,A;T	205,1;206,1;207	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4418	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3474	158.6	1	SNP	p	S87W	0	.	.	259	261	AGT	797	799	AGT	206;207;207	A,T;G,A;T	205,1;206,1;207	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4418	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3474	158.6	1	SNP	p	S87R	0	.	.	259	261	AGT	797	799	AGT	206;207;207	A,T;G,A;T	205,1;206,1;207	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4418	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3474	158.6	1	SNP	p	S88P	0	.	.	262	264	TCC	800	802	TCC	211;211;214	T;C;C	211;211;214	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3788	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2923	161.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1659	1661	GGC	217;216;215	G,T;G;C	216,1;216;215	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3256	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	142.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1504	1506	GCA	199;200;200	G,C;C,G;A	198,1;199,1;200	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3256	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	142.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1507	1509	ATC	199;197;198	A;T;C	199;197;198	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3256	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	142.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1519	1521	GTG	205;204;204	G;T;G	205;204;204	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3256	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	142.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1519	1521	GTG	205;204;204	G;T;G	205;204;204	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3256	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	142.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2023	2025	ACC	180;180;181	A;C;C	180;180;181	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3256	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	142.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2077	2079	GCG	174;174;175	G,A;C;G	173,1;174;175	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3256	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	142.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2077	2079	GCG	174;174;175	G,A;C;G	173,1;174;175	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3256	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	142.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2200	2202	GGC	186;184;187	G;G;C	186;184;187	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3256	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	142.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2209	2211	GGC	181;183;183	G;G;C,A	181;183;182,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3256	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	142.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2227	2229	CCG	169;168;164	C,A;C,T;G,C	167,2;167,1;163,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	4566	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3498	162.8	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1847	1849	CTG	209;208;208	C,T;T,C;G,C	208,1;207,1;207,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2346	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2190	133.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	712	712	C	165	C	165	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2182	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1738	156.1	0	.	p	.	0	I45V	NONSYN	133	135	ATT	544	546	GTT	197;198;198	G,C;T;T	196,1;197;198	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2182	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1738	156.1	0	.	p	.	0	N121S	NONSYN	361	363	AAC	772	774	AGC	166;168;168	A,G;G;C	164,2;168;168	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2182	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1738	156.1	0	.	p	.	0	N122K	NONSYN	364	366	AAC	775	777	AAA	170;168;164	A,G;A;A	169,1;168;164	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2182	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1738	156.1	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	838	840	GAA	163;165;165	G,T;A;A	162,1;165;165	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2182	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1738	156.1	0	.	p	.	0	V151A	NONSYN	451	453	GTA	862	864	GCA	169;170;169	G;C;A	169;170;169	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2182	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1738	156.1	0	.	p	.	0	K207_M208insK	INS	619	619	A	1030	1030	A	183	A	183	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2182	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1738	156.1	0	.	p	.	0	A212S	NONSYN	634	636	GCA	1048	1050	TCA	175;172;173	T;C,A;A	175;171,1;173	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2182	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1738	156.1	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	1165	1165	T	167	T,C	166,1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	256	porB3	990	162	93.83	porB3.l15.c30.ctg.1	164	63.3	0	.	p	.	0	S273T	NONSYN	817	819	TCG	62	64	ACT	83;83;83	A;C,A;T	83;82,1;83	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	256	porB3	990	162	93.83	porB3.l15.c30.ctg.1	164	63.3	0	.	p	.	0	D276S	NONSYN	826	828	GAT	71	73	AGT	83;83;83	A;G;T	83;83;83	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	256	porB3	990	162	93.83	porB3.l15.c30.ctg.1	164	63.3	0	.	p	.	0	K278D	NONSYN	832	834	AAA	77	79	GAC	83;83;83	G;A;C	83;83;83	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	256	porB3	990	162	93.83	porB3.l15.c30.ctg.1	164	63.3	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	80	82	TAC	83;83;83	T;A;C	83;83;83	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7886	rpoB	4179	4179	100.0	rpoB.l6.c17.ctg.1	5101	192.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2107	2109	AAT	231;230;232	A;A;T	231;230;232	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1162	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1260	114.5	1	SNP	p	V57M	1	.	.	169	171	ATG	661	663	ATG	226;223;223	A,C;T,A;G	225,1;222,1;223	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
